Patents by Inventor H. William Strauss

H. William Strauss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10201623
    Abstract: The present invention provides new methods for cardiac imaging and related medical applications thereof. In some embodiments, the present invention provides a method for the diagnosis of cardiovascular diseases, conditions, or disorders. In some embodiments, the present invention provides a method for the treatment or prevention of cardiovascular diseases, conditions, or disorders. In some embodiments, the present invention provides methods for monitoring the effect of cancer treatment on the heart, and/or methods for monitoring a cancer treatment regimen. In some embodiments, the present invention provides a method for selecting subjects for a test or treatment. In some embodiments, the present invention provides a method for determining the dosage of a drug. In some embodiments, the present invention provides methods for determining the risk of a cardiovascular disease, for assessing risk of a cardiovascular disease, and/or for determining the risk of heart attack.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: February 12, 2019
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Mark Dunphy, H. William Strauss, Gabriela Chiosis
  • Publication number: 20160015837
    Abstract: The present invention provides new methods for cardiac imaging and related medical applications thereof. In some embodiments, the present invention provides a method for the diagnosis of cardiovascular diseases, conditions, or disorders. In some embodiments, the present invention provides a method for the treatment or prevention of cardiovascular diseases, conditions, or disorders. In some embodiments, the present invention provides methods for monitoring the effect of cancer treatment on the heart, and/or methods for monitoring a cancer treatment regimen. In some embodiments, the present invention provides a method for selecting subjects for a test or treatment. In some embodiments, the present invention provides a method for determining the dosage of a drug. In some embodiments, the present invention provides methods for determining the risk of a cardiovascular disease, for assessing risk of a cardiovascular disease, and/or for determining the risk of heart attack.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 21, 2016
    Inventors: Mark DUNPHY, H. William STRAUSS, Gabriela CHIOSIS
  • Patent number: 7666389
    Abstract: A method of imaging apoptosis in vivo, using radiolabeled annexin, is described.
    Type: Grant
    Filed: November 15, 2007
    Date of Patent: February 23, 2010
    Assignees: The Board of Trustees of the Leland Stanford Junior University, University of Washington
    Inventors: Francis G. Blankenberg, Peter D. Katsikis, H. William Strauss, Jonathan F. Tait
  • Publication number: 20080138279
    Abstract: A method of imaging apoptosis in vivo, using radiolabeled annexin, is described.
    Type: Application
    Filed: November 15, 2007
    Publication date: June 12, 2008
    Applicants: The Board of Trustees of the Leland Stanford Junior University, University of Washington
    Inventors: Francis G. Blankenberg, H. William Strauss, Jonathan F. Tait, Peter D. Katsikis
  • Publication number: 20040170603
    Abstract: A method of imaging apoptosis in vivo, using radiolabeled annexin, is described. Methods for tumor radiotherapy are also provided.
    Type: Application
    Filed: March 5, 2004
    Publication date: September 2, 2004
    Applicants: The Board of Trustees of the Leland Stanford Junior University, Theseus Imaging Corporation
    Inventors: H. William Strauss, Francis G. Blankenberg, Allan M. Green, Neil Steinmetz
  • Patent number: 6782289
    Abstract: Methods, devices, and kits, for assessing luminal lesions are provided. The subject devices comprise an intraluminal detector capable of sensing radioactive or other labels. In the subject methods, a detectable marker is introduced to a body lumen, either into the lumen itself or systemically in patient circulation, and localizes at a lesion. The detector is introduced into the body lumen and the distribution of a localized marker detected in situ. The information is useful for a number of purposes including the identification of unstable plaque in patients suffering from atherosclerotic disease.
    Type: Grant
    Filed: September 26, 2000
    Date of Patent: August 24, 2004
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventor: H. William Strauss
  • Patent number: 6726895
    Abstract: A method of imaging apoptosis in vivo, using radiolabeled annexin, is described. Methods for tumor radiotherapy are also provided.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: April 27, 2004
    Assignees: Board of Trustees of the Leland Stanford Junior University, Theseus Imaging Corporation
    Inventors: H. William Strauss, Francis G. Blankenberg, Allan M. Green, Neil Steinmetz
  • Publication number: 20030152513
    Abstract: The present invention relies on the affinity of stressed or apoptotic cells for exogenously administered annexin V to create a multi-functional molecular probe that can be simultaneously used for imaging (localization of unstable plaque within the body) and therapy (treatment of unstable plaque).
    Type: Application
    Filed: September 6, 2002
    Publication date: August 14, 2003
    Applicant: IMETRIX, INC.
    Inventors: Francis G. Blankenberg, Jagat Narula, H. William Strauss, Vartan Ghazarossian
  • Publication number: 20030036699
    Abstract: Methods, devices, and kits, for assessing luminal lesions rely on intraluminal detection of labeled annexin. Annexin coupled to a detectable marker is introduced to a body lumen, either into the lumen itself or systemically in patient circulation, and localizes at a lesion. The detector is introduced into the body lumen and the localize distribution of the detectable marker is detected in situ. The information is useful for a number of purposes including the identification of unstable plaque in patients suffering from atherosclerotic disease.
    Type: Application
    Filed: February 21, 2002
    Publication date: February 20, 2003
    Applicant: IMETRx, Inc.
    Inventor: H. William Strauss
  • Publication number: 20020115931
    Abstract: Methods and systems for localizing intravascular lesion in a body lumen. In exemplary embodiments, the methods comprise providing or acquiring an image of the body lumen and displaying information about the lesion with or on the image. In some configurations the information is obtained with an intravascular catheter.
    Type: Application
    Filed: February 21, 2001
    Publication date: August 22, 2002
    Inventors: H. William Strauss, Leon Kaufman, Vartan Ghazarossian
  • Patent number: 6197278
    Abstract: A method of imaging apoptosis in vivo, using radiolabeled annexin, is described.
    Type: Grant
    Filed: April 29, 1998
    Date of Patent: March 6, 2001
    Assignees: The Board of Trustees of the Leland Stanford Junior University, University of Washington
    Inventors: Francis G. Blankenberg, H. William Strauss, Jonathan F. Tait, Peter D. Katsikis
  • Patent number: 5792444
    Abstract: The invention relates to a method of detecting a site of infection or inflammation, and a method for treating such infection or inflammation, in an individual by administering to the individual a diagnostically or therapeutically effective amount of detectably labeled, therapeutic, or therapeutically-conjugated, chemotactic peptide that accumulates substantially at the infected or inflamed site, said chemotactic peptide having the general structureX--Y--Leu--Phe--?Z!.sub.n --Wwherein:X is an amino protecting group,Y is an amino acid residue,Z is a spacer sequence,n is 0 or 1, andW is a labeling or attachment substituent.
    Type: Grant
    Filed: October 22, 1993
    Date of Patent: August 11, 1998
    Assignees: The General Hospital Corporation, Johnson Matthey, Inc., Ortho Pharmaceutical Corporation
    Inventors: Alan J. Fischman, Howard F. Solomon, Claudia K. Derian, Gary J. Bridger, John D. Higgins, III, Scott K. Larsen, Pedro E. Hernandez, Robert H. Rubin, H. William Strauss, Anthony J. Fuccello, Daniel J. Kroon
  • Patent number: 5363846
    Abstract: The invention relates to a method of detecting an inflammation site in an individual by administering to the individual a diagnostically effective amount of detectably labeled immunoglobulin or fragment thereof, wherein the immunoglobulin substantially accumulates at the site when the site is inflamed.
    Type: Grant
    Filed: May 21, 1990
    Date of Patent: November 15, 1994
    Assignee: The General Hospital Corporation
    Inventors: Robert H. Rubin, H. William Strauss
  • Patent number: 5277894
    Abstract: The invention relates to a method of detecting an Fc receptor-expressing tumor site in an individual by administering to the individual a diagnostically effective amount of detectably-labeled non-specific immunoglobulin or Fc or Fc' fragment thereof, wherein the immunoprotein substantially accumulates at the site when the site bears such a tumor. By using a therapeutically-labeled specific or non-specific immunoglobulin or Fc or Fc' fragment thereof, the tumor may be treated therapeutically.
    Type: Grant
    Filed: February 25, 1993
    Date of Patent: January 11, 1994
    Assignee: The General Hospital Corporation
    Inventors: H. William Strauss, Robert H. Rubin, Ban A. Khaw, Faina Shtern
  • Patent number: 5200178
    Abstract: The invention relates to a method of detecting an Fc receptor-expressing tumor site in an individual by administering to the individual a diagnostically effective amount of detectably-labeled non-specific immunoglobulin or Fc or Fc' fragment thereof, wherein the immunoprotein substantially accumulates at the site when the site bears such a tumor. By using a therapeutically-labeled specific or non-specific immunoglobulin or Fc or Fc' fragment thereof, the tumor may be treated therapeutically.
    Type: Grant
    Filed: July 16, 1991
    Date of Patent: April 6, 1993
    Assignee: The General Hospital Corporation
    Inventors: H. William Strauss, Robert H. Rubin, Ban An Khaw, Faina Shtern
  • Patent number: 4952393
    Abstract: Method using technetium-99m imaging agents for the study, detection or diagnosis of ischemic, infarcted or diseased tissue. The imaging agents comprise a complex of technetium-99 m and glucarate.
    Type: Grant
    Filed: October 7, 1988
    Date of Patent: August 28, 1990
    Assignee: The General Hospital Corporation
    Inventors: Harvey J. Berger, Ban A. Khaw, Koon Y. Pak, H. William Strauss
  • Patent number: 4926869
    Abstract: The invention relates to a method of detecting an inflammation site in an individual by administering to the individual a diagnostically effective amount of detectably labeled immunoglobulin or fragment thereof, wherein the immunoglobulin substantially accumulates at the site when the site is inflamed.
    Type: Grant
    Filed: November 13, 1987
    Date of Patent: May 22, 1990
    Assignee: The General Hospital Corporation
    Inventors: Robert H. Rubin, H. William Strauss
  • Patent number: 4633881
    Abstract: An ambulatory ventricular function anaylzer system is provided. The ambulatory ventricular function analyzer system is carried by a garment worn by a cardiac patient and includes ECG electrodes, a main left ventricular probe detector, and a background lung probe detector for providing diagnostically useful information while the patient goes about the normal activities of daily life. An information processing sub-system including a microprocessor responds to the electrode signal and to the probe signals and provides composite data representative of the ECG activity, the background lung time-activity, the left ventricular time-activity, and an R-wave histogram averaged over multiple cardiac cycles.
    Type: Grant
    Filed: July 1, 1982
    Date of Patent: January 6, 1987
    Assignee: The General Hospital Corporation
    Inventors: Richard H. Moore, H. William Strauss, Nathaniel M. Alpert
  • Patent number: 4572197
    Abstract: A vest for positioning medical instrumentation about the human or animal torso to provide ambulatory monitoring of patient cardiac functions or administration of medication or therapy with reasonable freedom of movement while maintaining precise positioning of the instrumentation relative to the torso. The vest functions to provide accurate placement of such instrumentation as a radioactive emission sensor for monitoring ejection fraction. The vest typically includes a sheet of a dimensionally rigid material such as a low density polymer tailored to fit between neck and hips and to surround the torso, terminating on the back. Straps are provided to fasten the sheet ends together at the back and to suspend it from the shoulders. The vest may also be instrumented to function as a transducer itself to detect chest expansion for heart beat or lung volume monitoring.
    Type: Grant
    Filed: June 1, 1984
    Date of Patent: February 25, 1986
    Assignee: The General Hospital Corporation
    Inventors: Richard H. Moore, H. William Strauss, Nathaniel M. Alpert
  • Patent number: RE35152
    Abstract: The invention relates to a method of detecting an inflammation site in an individual by administering to the individual a diagnostically effective amount of detectably labeled immunoglobulin or fragment thereof, wherein the immunoglobulin substantially accumulates at the site when the site is inflamed.
    Type: Grant
    Filed: May 20, 1992
    Date of Patent: February 6, 1996
    Assignee: The General Hospital Corporation
    Inventors: Robert H. Rubin, H. William Strauss